The paper compares methods for estimating heterogeneous treatment effects using multiple randomized trials.
problem Estimating heterogeneous treatment effects reliably and precisely with a single dataset is challenging.
method Non-parametric approaches for estimating heterogeneous treatment effects using data from multiple trials.
result Methods that directly allow for heterogeneity of the treatment effect across trials perform better than those that do not.
New method detects biomarker-treatment interactions in clinical trials.
problem Detecting interactions between high-dimensional biomarkers and treatments in randomized trials.
method Two-stage penalized regression screening using ridge regression for multivariate screening.
result Ridge regression screening provides greater power than traditional methods in correlated data.
New study shows non-adaptive trials can be outperformed by adaptive designs in treatment selection.
problem Determining the best allocation of resources in clinical trials.
method Analysis of batched arm elimination designs and comparison with completely randomized trials.
result Simple adaptive designs universally and strictly dominate non-adaptive completely randomized trials for at least three treatment arms.
QR-learner estimates individual treatment effects using external data.
problem Limited power to detect individual treatment effects in randomized trials.
method Model-agnostic learner that estimates conditional average treatment effects (CATE) using external data.
result QR-learner reduces mean squared error and can recover true CATE.
Combines trial and observational data to improve policy evaluation.
problem External validity of randomized trial results in target populations.
method Uses covariate data to model trial sampling and certifies policy evaluations.
result Valid trial-based policy evaluations under model miscalibration.
A new method uses randomized trials to estimate the strength of unobserved confounding.
problem Unobserved confounding compromises causal conclusions from non-randomized studies.
method Designs a statistical test to detect unobserved confounding strength and estimates a lower bound.
result Estimates an asymptotically valid lower bound on unobserved confounding strength.
New methods improve subgroup analysis in trials with limited data.
problem Limited sample sizes in subgroup analyses of randomized controlled trials.
method Two TMLEs that borrow information from non-subgroup participants.
result Improved precision in subgroup-specific treatment effect estimates.
G-computation improves clinical trial power with machine learning.
problem Balancing prognostic factors in randomized trials to prevent near-confounders.
method G-computation with penalized models (Lasso, Elasticnet) and algorithm-based methods (neural network, SVM, super learner).
result G-computation with Elasticnet and splines reduces variance and increases power in RCTs.
New framework for adaptive clinical trials to address real-world challenges.
problem Real-world challenges in post-regulatory clinical trials.
method RFAN framework integrating regulatory constraints and treatment policy value.
result Empirical evaluation of RFAN's performance.
Adaptive Prespecification improves precision in randomized trials.
problem Selecting optimal covariates for precision in randomized trials.
method Adaptive Prespecification using V-fold cross-validation and influence curve-squared loss function.
result Substantial gains in precision, equivalent to 20-43% reductions in sample size for the same power.
New study shows limits to classifying brain activity from randomized EEG trials.
problem Classifying human brain activity from image stimuli using EEG is challenging.
method Used randomized trials on a larger dataset (20x) to avoid stimulus-time confound.
result Classification accuracy is marginally above chance and statistically significant.
Machine learning boosts RCT efficiency by controlling type I error and improving statistical power.
problem Improving statistical efficiency in RCTs with complex covariate adjustments.
method Machine learning-assisted adjustment under Rosenbaum's framework for exact tests.
result The proposed method robustly controls type I error and significantly boosts statistical efficiency.
WHOMP optimizes randomized controlled trials by minimizing subgroup bias.
problem Minimizing subgroup bias in randomized controlled trials.
method Wasserstein Homogeneity Partition (WHOMP) method.
result WHOMP optimally minimizes type I and type II errors in trials.
New estimator improves policy evaluation in resource allocation RCTs.
problem Difficulty in evaluating policies optimizing limited resource allocation through RCTs.
method Proposes a novel estimator involving retrospective reshuffling of participants across experimental arms.
result The new estimator provides more accurate policy evaluations than common methods.
Optimum in Convex Hulls (OCH) generalizes clinical trial results to broader populations.
problem Clinical trials exclude confounding but limit recruitment; observational data are more inclusive but suffer from confounding.
method OCH uses convex hulls of conditional expectations or densities to approximate the true treatment effect from both observational and trial data.
result OCH estimates the treatment effect with state-of-the-art accuracy in terms of both expectations and densities.
Machine learning improves trial analysis precision by adjusting for prognostic variables.
problem Improving precision in randomized trial analyses using covariate adjustment.
method Targeted machine learning estimation (TMLE) with adaptive pre-specification.
result Maximized empirical efficiency through cross-validated variance minimization.
A-TMLE estimates ATE from RCT and RWD, achieving super-efficiency.
problem Estimating ATE from RCT and RWD data.
method Adaptive-TMLE framework for decomposing and estimating ATE.
result A-TMLE is root-n consistent and asymptotically normal, achieving super-efficiency.
Novel strategy benchmarks observational studies against randomized trials.
problem Benchmarking observational studies for treatment effect bias.
method Statistical test for null hypothesis of treatment effect difference.
result Valid lower bound on maximum bias strength for any subgroup.
Assessing heterogeneous treatment effects has become a growing interest in advancing precision medicine. Individualized treatment effects (ITE) play a critical role in such an endeavor. Concerning experimental data collected from randomized trials, we put forward a method, termed random forests of interaction trees (RF…
Participants enrolled into randomized controlled trials (RCTs) often do not reflect real-world populations. Previous research in how best to translate RCT results to target populations has focused on weighting RCT data to look like the target data. Simulation work, however, has suggested that an outcome model approach …
Causal ML methods failed to validate their personalized treatment effects in two large trials.
problem Validating causal machine learning methods for personalized treatment effects in precision medicine.
method Assessed 17 mainstream causal heterogeneity ML methods using two large randomized controlled trials.
result None of the ML methods reliably validated their performance, internal or external, showing significant discrepancies between training and test data.
Improves trial efficiency by adjusting for historical prognostic scores.
problem Reducing statistical uncertainty in randomized trial estimates.
method Linear covariate adjustment using a prognostic model trained on historical data.
result Prognostic covariate adjustment achieves minimum variance and reduces mean-squared error.
The paper evaluates index-based allocation policies using data from randomized control trials.
problem Evaluating index-based allocation policies in resource-scarce scenarios.
method Using data from randomized control trials, the paper introduces an efficient estimator and methods for computing asymptotically correct confidence intervals.
result Valid statistical conclusions can be drawn for index-based allocation policies.
Two-stage TMLE reduces bias and improves efficiency in CRTs.
problem Differential outcome measurement and imbalance in baseline predictors in CRTs.
method Two-stage targeted minimum loss-based estimator (TMLE) to adjust for baseline covariates.
result Our approach nearly eliminates bias due to differential outcome measurement.
Machine learning improves learning and memory retention by optimizing study sessions.
problem Improving learning and memory retention methods for factual material.
method Large-scale randomized controlled trial with machine learning optimization of study sessions.
result Study sessions optimized with machine learning lead to 67% longer retention and 50% higher return rate.
This study evaluates subgroup analysis methods for time-to-event outcomes in randomized controlled trials.
problem Identifying subgroups of good responders in non-significant randomized controlled trials.
method Evaluation of several subgroup analysis algorithms for time-to-event outcomes using synthetic and semi-synthetic data.
result Provides a new synthetic and semi-synthetic data generation process and an open-source Python package for benchmarking.
New methods improve causal inference generalization using trial and observational data.
problem Limited trial data makes generalizing causal inferences to target populations statistically infeasible.
method Develops algorithms that combine trial and observational data to estimate complex nuisance functions.
result Improves generalization of causal inferences when the additional observational study is high-quality.
Randomized Controlled Trials (RCTs) are the gold standard for comparing the effectiveness of a new treatment to the current one (the control). Most RCTs allocate the patients to the treatment group and the control group by uniform randomization. We show that this procedure can be highly sub-optimal (in terms of learnin…
Detection of interactions between treatment effects and patient descriptors in clinical trials is critical for optimizing the drug development process. The increasing volume of data accumulated in clinical trials provides a unique opportunity to discover new biomarkers and further the goal of personalized medicine, but…
The P300 event-related potential (ERP), evoked in scalp-recorded electroencephalography (EEG) by external stimuli, has proven to be a reliable response for controlling a BCI. The P300 component of an event related potential is thus widely used in brain-computer interfaces to translate the subjects' intent by mere thoug…
DARTS optimizes covariate selection in trials with limited data.
problem Limited budget for high-dimensional pretreatment data.
method Dynamic Adaptive Rerandomization via Thompson Sampling (DARTS).
result DARTS efficiently concentrates budget on informative features.
Framework for estimating treatment effects using external control data.
problem Improving efficiency in estimating average treatment effects (ATE) in hybrid trials.
method Developed a formal causal inference framework based on exchangeability assumptions and graphical criteria. Proposed estimators and efficient doubly-robust methods.
result Established finite-sample performance and demonstrated application to spinal muscular atrophy trial.
DWTS uses observational data to improve clinical trial efficiency.
problem Lack of definitive conclusions from randomized clinical trials due to insufficient patient cohorts and confounding biases.
method DWTS combines observational data with randomized clinical trials using Doubly Debiased LASSO (DDL) to identify reliable covariates.
result DWTS reduces cumulative regret in clinical trials compared to standard methods.
A cornerstone of human statistical learning is the ability to extract temporal regularities / patterns from random sequences. Here we present a method of computing pattern time statistics with generating functions for first-order Markov trials and independent Bernoulli trials. We show that the pattern time statistics c…
The study optimizes free trial lengths to boost subscriptions and consumer loyalty.
problem Optimizing free trial lengths to maximize customer acquisition and retention.
method A large-scale field experiment with personalized policy design and evaluation.
result Personalized free trial policies outperform uniform trial lengths.
Framework tests CATE homogeneity across trials and evaluates confounding.
problem Assessing treatment effect consistency across randomized and observational studies.
method Leverages multiple randomized trials to test CATE homogeneity and compares with observational data.
result Identifies potential confounding and effect heterogeneity in treatment effects.
New methods optimize personalized treatment assignment in trials with many arms.
problem Poor performance of standard methods in trials with many treatment arms.
method Regularized and clustered joint assignment forest algorithm.
result Gains in predicting arm-wise outcomes and utility gains from personalization.
TrialGraph uses graph machine learning to improve clinical trial design and predict side effects.
problem Complexity and cost in clinical trials hinder drug development.
method Curated clinical trial data set converted to graph-structured formats, applied graph machine learning algorithms.
result MetaPath2Vec algorithm performed exceptionally well, improving prediction accuracy.
Study uses machine learning to optimize antibiotic therapy for MRSA skin infections.
problem Optimizing antibiotic choice for MRSA skin infections due to reduced treatment options and side effects.
method Propensity score matching, machine learning models (SVM, RF, LASSO), counterfactual analysis.
result RF model shows stronger treatment heterogeneity and potential for therapy change.
Observed events in recommendation are consequence of the decisions made by a policy, thus they are usually selectively labeled, namely the data are Missing Not At Random (MNAR), which often causes large bias to the estimate of true outcomes risk. A general approach to correct MNAR bias is performing small Randomized Co…
New method uses observational data to improve trial design efficiency.
problem Scarce randomized controlled trials; inefficiency of using observational data.
method Active Residual Learning, R-Design framework, R-EPIG criterion.
result Efficiently estimating residuals to correct observational bias improves trial design.
New method uses latent variables to estimate treatment effects from single-arm trials.
problem Estimating treatment effects from single-arm trials due to lack of external control groups.
method Latent-variable modeling with amortized variational inference for patient matching and direct effect estimation.
result Improved performance in direct treatment effect estimation and effect estimation via patient matching compared to previous methods.
Proposes a method to correct for covariate shift in meta-analysis of randomized trials.
problem Invalidation of standard IPD meta-analysis due to covariate shift across studies.
method Placebo-anchored transport framework that treats source-trial outcomes as proxy signals and target-trial placebo outcomes as gold labels.
result Yields target-identified effect estimates in connected targets and a principled screen--then--transport procedure in disconnected targets.
Digital twins improve single-arm trials by providing robust treatment effect estimates.
problem Lack of control arms in single-arm trials limits their gold-standard evidence.
method Outcome-model-based synthetic controls using machine learning models trained on historical data.
result Digital twins offer more robust treatment effect estimates and principled corrections.
New approach estimates treatment effects from decentralized data.
problem Estimating treatment effects from multiple studies with limited data.
method Three classes of ATE estimators derived from Plug-in G-Formula.
result Asymptotic variance of estimators for linear models derived.
Forest-based methods estimate heterogeneous treatment effects, blending strengths for better performance.
problem Estimating heterogeneous treatment effects in randomized and observational studies.
method Causal forests and model-based forests, blending strengths for better performance.
result Local centering of treatment indicator and propensities is crucial for good performance in randomized trials.
Proposes a new Q-learning method for survival outcomes in clinical trials.
problem Incomplete follow-up data and nonlinear covariate effects in clinical trials.
method Combines Buckley-James boosting with flexible base learners for estimating optimal treatment regimes.
result Improves treatment decision accuracy and stability in longitudinal clinical trials.
The paper proposes a method to assess surrogate heterogeneity in non-randomized data.
problem Lack of methods to evaluate surrogate heterogeneity in non-randomized data.
method Proposes a framework using meta-learners to assess surrogate heterogeneity in real-world data.
result Identifies individuals for whom the surrogate is a valid replacement of the primary outcome.